A Pilot Study to Determine the Feasibility of Conducting a Randomized Clinical Trial Comparing Fondaparinux Sodium (Arixtra) Once Daily With Enoxaparin (Lovenox) Twice Daily With Respect to Preventing VTE After Bariatric Surgery

Trial Profile

A Pilot Study to Determine the Feasibility of Conducting a Randomized Clinical Trial Comparing Fondaparinux Sodium (Arixtra) Once Daily With Enoxaparin (Lovenox) Twice Daily With Respect to Preventing VTE After Bariatric Surgery

Completed
Phase of Trial: Phase 0

Latest Information Update: 19 Aug 2014

At a glance

  • Drugs Enoxaparin sodium (Primary) ; Fondaparinux sodium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 24 Jun 2013 Planned end date changed from 1 Jun 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top